tetrabenazine has been researched along with Disease Models, Animal in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (11.90) | 29.6817 |
| 2010's | 25 (59.52) | 24.3611 |
| 2020's | 3 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, YH; Hoffer, BJ; Huang, EY; Kuo, TT; Ma, KH; Olson, L; Tseng, KY; Wang, V | 1 |
| Jaggi, AS; Kumar, M; Singh, N | 1 |
| Chen, ZA; Hsiao, IT; Hsu, CH; Huang, SL; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC | 1 |
| Gjedde, A; Jakobsen, S; Landau, AM; Phan, JA; Romero-Ramos, M; Stokholm, K; Vang, K; Zareba-Paslawska, J | 1 |
| Alstrup, AKO; Brooks, DJ; Doudet, DJ; Glud, AN; Landau, AM; Lillethorup, TP; Mikkelsen, TW; Nielsen, EH; Orlowski, D; Sørensen, JCH; Zaer, H | 1 |
| Brown, CA; Flores, HP; Karimi, M; Loftin, SK; Moerlein, SM; Perlmutter, JS; Tian, L; Videen, TO | 1 |
| Dinelle, K; Doudet, DJ; Flores, J; Jing, Y; Mackey, S | 1 |
| Brown, CA; Flores, H; Karimi, MK; Loftin, SK; Moerlein, SM; Perlmutter, JS; Su, Y; Tabbal, SD; Tian, L | 1 |
| Baqi, Y; Barber, J; Correa, M; Lee, CA; Lendent, C; López-Cruz, L; Milligan, M; Müller, CE; Nunes, EJ; Pardo, M; Podurgiel, SJ; Salamone, JD; Thompson, A; Valverde, O; Yohn, SE | 1 |
| Chan, P; Kung, HF; Liu, Y; Pan, X; Tang, R; Tao, G; Yue, F; Zhu, L | 1 |
| Baqi, Y; Correa, M; Freeland, C; Hart, EE; López-Cruz, L; Müller, CE; Nunes, EJ; Randall, PA; Salamone, JD; Yohn, SE | 1 |
| Casaca-Carreira, J; Jahanshahi, A; Janssen, ML; Oosterloo, M; Santegoeds, RG; Temel, Y; Vlamings, R; Zeef, DH | 1 |
| Gupta, S; Sharma, B | 1 |
| Kawakami, D; Machida, K; Miki, M | 1 |
| Blesa, J; Cavada, C; Hornykiewicz, O; Obeso, JA; Pifl, C; Rajput, A; Rajput, AH; Reither, H | 1 |
| Collantes, M; Delgado, M; Ecay, M; Gago, B; Iglesias, E; Juri, C; Marín, C; Molinet-Dronda, F; Obeso, JA; Peñuelas, I; Prieto, E; Quiroga-Varela, A | 1 |
| Contreras-Mora, HM; Correa, M; Milligan, MN; Podurgiel, SJ; Purcell, LJ; Salamone, JD; Yohn, SE | 1 |
| Czekaj, J; Kos, T; Popik, P; Skolnick, P | 1 |
| Arponen, E; Asser, A; Bergquist, J; Eltermaa, M; Grönroos, T; Haaparanta-Solin, M; Kõks, S; Lindmäe, H; Nairismägi, J; Piip, P; Rinne, JO; Sauk, M; Snellman, A; Soomets, U; Taba, P | 1 |
| Chan, MH; Chao, KT; Chen, ZA; Ee, TW; Hsiao, IT; Hsu, CH; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC | 1 |
| Alexander, M; Burton, NC; Griswold, M; Guilarte, TR; McGlothan, JL; Pham, L; Schneider, JS; Syversen, T; Verina, T; Wong, DF; Zhou, Y | 1 |
| Arbizu, J; Blesa, J; Cavada, C; Collantes, M; García-García, D; Iglesias, E; Juri, C; Martí-Climent, J; Obeso, JA; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
| Hou, C; Kung, HF; Lieberman, BP; Oya, S; Parhi, AK; Ploessl, K; Wang, JL | 1 |
| Rehavi, M; Simchon, Y; Weizman, A | 1 |
| Kazantsev, AG; Krobitsch, S | 1 |
| Chao, KT; Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Tsao, HH; Weng, YH; Wey, SP; Yen, TC | 1 |
| Bhatia, S; Lokitz, SJ; Mathis, JM; Moon, LT; Orchard, EA; Penman, AD; Tainter, KH; Terry, T; Toomey, JS | 1 |
| Rehavi, M; Schwartz, K; Weizman, A; Yadid, G | 1 |
| Goland, R; Hardy, M; Harris, PE; Kilbourn, M; Leibel, R; Maffei, A; Mann, JJ; Raffo, A; Saxena, C; Simpson, N; Souza, F; Van Heertum, R | 1 |
| Andersson, DR; Bergquist, F; Nissbrandt, H | 1 |
| Adams, RJ; Alexander, M; Brasić, JR; Burton, NC; Chen, MK; Guilarte, TR; Kumar, A; Kuwabara, H; McGlothan, JL; Verina, T; Wong, DF; Zhou, Y | 1 |
| Nagayama, H; Tachiki, KH; Takahashi, R; Tateishi, T; Yoshida, H | 1 |
| Glotzbach, RK; Irwin, GH; Kent, TA; Preskorn, SH; Solnick, JV | 1 |
| Tateishi, N | 1 |
| Kido, A; Nagayama, H; Nakamura, E; Nishiwaki, K; Tachiki, KH; Takagi, A; Takahashi, R; Tateishi, T | 1 |
| Baizman, ER; Ezrin, AM; Ferrari, RA; Luttinger, D | 1 |
| Babington, RG; Wedeking, PW | 1 |
| Anton, AH; Martin, L | 1 |
| Kido, A; Morita, T; Nagayama, H; Takahashi, R | 1 |
| Calne, DB; Webster, RA | 1 |
2 review(s) available for tetrabenazine and Disease Models, Animal
| Article | Year |
|---|---|
[Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].
Topics: Adrenergic Uptake Inhibitors; Animals; Biogenic Monoamines; Brain; Clinical Trials, Phase III as Topic; Disease Models, Animal; Humans; Huntington Disease; Male; Mice; Rats; Receptors, Dopamine D1; Tablets; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2014 |
Huntington's disease: From molecular basis to therapeutic advances.
Topics: Adrenergic Uptake Inhibitors; Animals; Cerebral Cortex; Disease Models, Animal; Humans; Huntingtin Protein; Huntington Disease; Mice; Mutation; Neostriatum; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Protein Conformation; Tetrabenazine; Trinucleotide Repeats | 2011 |
40 other study(ies) available for tetrabenazine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Mice; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Tetrabenazine | 2022 |
Exploring the anti-stress effects of imatinib and tetrabenazine in cold-water immersion-induced acute stress in mice.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Brain; Cold Temperature; Corticosterone; Disease Models, Animal; Exploratory Behavior; Female; Imatinib Mesylate; Immersion; Locomotion; Male; Mice; Motor Activity; Protein Kinase Inhibitors; Social Behavior; Stress, Psychological; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2020 |
[
Topics: Acetylcysteine; Animals; Brain; Disease Models, Animal; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tetrabenazine | 2017 |
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Carbon Radioisotopes; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals; Rats; Rats, Transgenic; Substantia Nigra; Synapses; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; HLA-DR Antigens; Magnetic Resonance Imaging; Movement Disorders; Positron-Emission Tomography; Substantia Nigra; Swine; Swine, Miniature; Synaptic Transmission; Tetrabenazine; Tyrosine 3-Monooxygenase | 2018 |
Validation of nigrostriatal positron emission tomography measures: critical limits.
Topics: Animals; Cocaine; Corpus Striatum; Disease Models, Animal; Fluorodeoxyglucose F18; Macaca mulatta; Magnetic Resonance Imaging; Male; MPTP Poisoning; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Reproducibility of Results; Substantia Nigra; Tetrabenazine | 2013 |
Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Topics: Acetylcysteine; Analysis of Variance; Animals; Carbon Isotopes; Cell Count; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hindlimb; Locomotion; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tetrabenazine; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.
Topics: Animals; Carbon Isotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Macaca mulatta; Magnetic Resonance Imaging; Male; Mesencephalon; MPTP Poisoning; Neurons; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine | 2013 |
The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Topics: Adrenergic Uptake Inhibitors; Animals; Catalepsy; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Jaw; Male; Mice; Mice, Knockout; Motor Activity; Movement; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tetrabenazine; Tremor; Vesicular Monoamine Transport Proteins; Xanthines | 2013 |
Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Linear Models; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Severity of Illness Index; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2014 |
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Topics: Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bupropion; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Feeding Behavior; Immunohistochemistry; Male; Microdialysis; Motivation; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance P; Tetrabenazine; Vesicular Monoamine Transport Proteins; Xanthines | 2013 |
An experimental model for Huntington's chorea?
Topics: Adrenergic Uptake Inhibitors; Animals; Disease Models, Animal; Huntington Disease; Hyperkinesis; Male; Rats; Rats, Transgenic; Tetrabenazine | 2014 |
Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Brain; Disease Models, Animal; Ditiocarb; Huntington Disease; Imidazoles; Imidazoline Receptors; Learning Disabilities; Memory Disorders; Motor Activity; NF-kappa B; Nitro Compounds; Nootropic Agents; Oxidative Stress; Propionates; Rats; Rats, Wistar; Tetrabenazine | 2014 |
Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
Topics: Aged; Aged, 80 and over; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Female; Homovanillic Acid; Humans; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Monoamine Transport Proteins | 2014 |
Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
Topics: Adrenergic Agents; Animals; Apomorphine; Brain; Carbon Radioisotopes; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Functional Laterality; Longitudinal Studies; Magnetic Resonance Imaging; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tetrabenazine | 2015 |
Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.
Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Jaw; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tetrabenazine; Tremor | 2015 |
Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Blepharoptosis; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phenols; Piperidines; Pyridines; Pyrimidines; Receptors, N-Methyl-D-Aspartate; Tetrabenazine | 2015 |
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese.
Topics: Animals; Autoradiography; Biomechanical Phenomena; Carbon Radioisotopes; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Gait; Illicit Drugs; Injections, Intraperitoneal; Male; Manganese; Mice, Inbred C57BL; Motor Activity; Positron-Emission Tomography; Propiophenones; Psychotropic Drugs; Radiopharmaceuticals; Random Allocation; Substance-Related Disorders; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2016 |
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biphenyl Compounds; Corpus Striatum; Disease Models, Animal; Fluorine Radioisotopes; Humans; Lignans; Mice; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.
Topics: Amphetamine; Animals; Cocaine; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Image Processing, Computer-Assisted; Macaca fascicularis; Male; Manganese; Parkinsonian Disorders; Positron-Emission Tomography; Substantia Nigra; Synaptic Transmission; Tetrabenazine; Tyrosine 3-Monooxygenase | 2008 |
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Topics: Animals; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dyskinesias; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Severity of Illness Index; Signal Processing, Computer-Assisted; Tetrabenazine | 2010 |
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.
Topics: Aniline Compounds; Animals; Autoradiography; Disease Models, Animal; Fluorine Radioisotopes; Male; p-Chloroamphetamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Radioactive Tracers; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Substrate Specificity; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |
The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Binding Sites; Brain; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Methylphenidate; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Synaptosomes; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
Topics: Animals; Binding Sites; Brain; Disease Models, Animal; Fluorine Radioisotopes; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2012 |
PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Norepinephrine; Positron-Emission Tomography; Tetrabenazine | 2012 |
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
Topics: Animals; Depression; Disease Models, Animal; Limbic System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
Topics: Animals; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Insulin; Insulin-Secreting Cells; Male; Papio; Positron-Emission Tomography; Radioligand Assay; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Tetrabenazine; Tissue Distribution; Vesicular Monoamine Transport Proteins | 2006 |
Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Topics: Adrenergic Uptake Inhibitors; Animals; Corpus Striatum; Dendrites; Disease Models, Animal; Dopamine; Extracellular Fluid; Female; Motor Activity; Movement; Movement Disorders; Neural Pathways; Parkinsonian Disorders; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Substantia Nigra; Synaptic Transmission; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2006 |
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.
Topics: Animals; Autoradiography; Brain; Carbon Isotopes; Carrier Proteins; Cocaine; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Glial Fibrillary Acidic Protein; Isoquinolines; Male; Neurons; Papio anubis; Parkinsonian Disorders; Positron-Emission Tomography; Raclopride; Tetrabenazine; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2008 |
Serotonin metabolism of animal model of depression.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Psychological; Depression; Disease Models, Animal; Dopamine; Humans; Hydroxyindoleacetic Acid; Male; Motor Activity; Movement; Norepinephrine; Rats; Serotonin; Tetrabenazine | 1981 |
Cerebromicrocirculatory defects in animal model of depression.
Topics: Amitriptyline; Animals; Brain; Carbon Dioxide; Cerebrovascular Circulation; Depression; Disease Models, Animal; Dopamine; Humans; Male; Microcirculation; Norepinephrine; Rats; Rats, Inbred Strains; Tetrabenazine | 1984 |
[Biochemical study of the animal model depression induced by tetrabenazine (author's transl)].
Topics: Animals; Behavior; Brain; Corticosterone; Depressive Disorder; Disease Models, Animal; Humans; Male; Rats; Serotonin; Tetrabenazine; Tryptophan | 1980 |
Animal model of depression. III. Mechanism of action of tetrabenazine.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Depression; Disease Models, Animal; Dopamine; Drug Synergism; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Motor Activity; Norepinephrine; Rats; Serotonin; Serotonin Antagonists; Tetrabenazine | 1978 |
Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Topics: Animals; Antidepressive Agents; Biological Transport; Blepharoptosis; Brain; Depression; Disease Models, Animal; Dogs; Dopamine; Imipramine; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Purkinje Cells; Pyrazoles; Rats; Reserpine; Serotonin; Synaptosomes; Tetrabenazine | 1987 |
The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).
Topics: 5-Hydroxytryptophan; Amphetamine; Anilides; Animals; Azathioprine; Body Weight; Chlorpheniramine; Cinnamates; Cyclophosphamide; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fenclonine; Immunosuppressive Agents; Mercaptopurine; Methylamines; Methysergide; Paralysis; Rats; Reserpine; Serotonin Antagonists; Tetrabenazine; Time Factors; Tranylcypromine | 1971 |
Toxicity of acids and bases after intraperitoneal injection.
Topics: Acetates; Acids; Alkalies; Analgesics; Anesthetics, Local; Animals; Anti-Bacterial Agents; Body Temperature; Chlorpromazine; Cold Temperature; Disease Models, Animal; Ethanol; Guanethidine; Hot Temperature; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Prednisolone; Propylene Glycols; Reserpine; Respiration; Shock, Septic; Tetrabenazine | 1970 |
An animal model of depression.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Conditioning, Classical; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Imipramine; Injections, Intraperitoneal; Male; Motor Activity; Rats; Tetrabenazine | 1974 |
Tremor induced by tetrabenazine.
Topics: Amobarbital; Animals; Body Temperature; Cats; Disease Models, Animal; Hot Temperature; Parkinson Disease; Scopolamine; Shivering; Sleep; Tetrabenazine; Tremor | 1969 |